Novel drug molecule offers hope for early Parkinson’s disease treatment

A novel drug molecule could potentially lead to new treatments to prevent Parkinson’s disease in younger patients, according to new research.

MilliporeSigma opens two mRNA manufacturing facilities

MilliporeSigma’s new large-scale mRNA drug substance manufacturing facility at the company’s headquarters in Darmstadt, Germany. Credit: MilliporeSigma/PRNewswire. Merck’s Life Science business MilliporeSigma has opened two

September 27, 2023

BioNTech expects up to $950M in Covid vaccine write-offs after Pfizer lowers expectations

Pfizer’s write-offs for its Covid-19 vaccine are having a ripple effect on partner BioNTech, which is expecting to write off up to €900 million ($950

October 17, 2023

NM-6603 by Nucmito for Colorectal Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.